FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin …
Sep 20, 2024 · The FTC accuses Caremark, ESI, and Optum of anticompetitive and unfair rebating practices that have artificially increased the list price of insulin drugs and shifted the cost to patients. The FTC seeks to end the PBMs' exploitative conduct and restore healthy competition in the insulin market.
Federal Trade Commission sues largest drug middlemen for
Sep 20, 2024 · CNN — The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that...
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · The FTC accuses CVS, Express Scripts and Optum of using unfair rebating practices and stifling competition for insulin drugs, raising the list price and making it harder for patients to access...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and...
FTC sues drug middlemen for allegedly inflating insulin prices
Sep 20, 2024 · The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while...
Federal Trade Commission accuses three drug middlemen of ... - NBC News
Sep 21, 2024 · The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
FTC Sues Drug Middlemen Over Inflated Insulin Prices - Forbes
Sep 20, 2024 · UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts have created a “perverse” drug rebate system that has “artificially inflated” the price of insulin ...
Feds sue pharmacy gatekeepers over high insulin costs
Sep 20, 2024 · The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.
FTC Sues Drug Middlemen Over Manipulating Insulin Market
Sep 20, 2024 · The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove...